Blog
RSS FeedPosted by Michael Wonder on 11 Jul 2019
Biosimilars continue to exhibit market failure
11 July 2019 - From their inception, biosimilars in the U.S. have faced headwinds. ...
Posted by Michael Wonder on 10 Jul 2019
Vaccine crisis leaves Australia’s immunisation record in tatters
9 July 2019 - Thousands of Australians are dying from the flu and meningococcal because lifesaving vaccines are not being approved, ...
Posted by Michael Wonder on 03 Jul 2019
Patients take outdated drugs because of PBS restrictions: UQ doctor
2 July 2019 - Patients are put at risk because the restrictions on drugs made by the Pharmaceutical Benefits Scheme ...
Posted by Michael Wonder on 24 Jun 2019
Forcing patients to switch to biosimilars puts them in uncharted waters
23 June 2019 - On May 27, the B.C. government announced a policy that will forcibly switch thousands of patients, ...
Posted by Michael Wonder on 24 Jun 2019
How big pharma suppresses ‘biosimilars’
23 June 2019 - Deals with insurers and pharmacy benefit managers at patient and taxpayer expense. ...
Posted by Michael Wonder on 20 Jun 2019
Combatting misinformation on biosimilars and preparing the market for them can save the U.S. billions
19 June 2019 - As politicians and policymakers debate effective ways to rein in rising health care costs, biosimilars represent ...
Posted by Michael Wonder on 18 Jun 2019
Advisory Council supports biosimilars in call for universal public drug coverage in Canada
17 June 2019 - A Canadian advisory council is recommending the use of biosimilars in a final report that lays ...
Posted by Michael Wonder on 16 Jun 2019
Government crackdown on abuse of antibiotics
17 June 2019 - Doctors could be prevented from prescribing repeats of antibiotics as authorities consider radical plans to contain ...
Posted by Michael Wonder on 13 Jun 2019
Realigning incentives to optimise generic and biosimilar prescribing
13 June 2019 - Drug prices and their impact on total US health care expenditures are again front of mind ...
Posted by Michael Wonder on 11 Jun 2019
Systematic literature review calls economic impact of switching to biosimilars "uncertain"
10 June 2019 - Biosimilar drugs are intended by their developers to provide a cost-saving alternative to brand-name biologics, and ...
Posted by Michael Wonder on 06 Jun 2019
Patients, physicians raise concerns with BC biosimilar non-medical switching policy
6 June 2019 - On 27 May, the Government of British Columbia announced a policy that will forcibly switch thousands ...
Posted by Michael Wonder on 05 Jun 2019
NHS publishes update on the use of biosimilars
5 June 2019 - The United Kingdom’s National Health Service (NHS) has published a new document for clinical and nonclinical ...
Posted by Michael Wonder on 04 Jun 2019
PBM launches oncology biosimilar medical pharmacy initiative
4 June 2019 - Ahead of the anticipated 2019 marketing of FDA-approved anticancer biosimilars in the United States, pharmacy benefit manager ...
Posted by Michael Wonder on 04 Jun 2019
Biosimilar uptake drivers - etanercept
3 June 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website. ...
Posted by Michael Wonder on 20 May 2019
PBS Pharmaceuticals in Hospitals Review
20 May 2019 - The Department of Health completed the PBS Pharmaceuticals in Hospitals Review to better understand how PBS medicines ...